Concepedia

Beth Ann McKenna

BA

7

Publications

333

Citations

7

H-Index

1997

Active since

Affiliations

Brandywine Photonics (United States)(Current)

Beth Ann McKenna is an author at Brandywine Photonics (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1997–2011

7

Publications

7

Mixed lineage kinase activity of indolocarbazole analogues

Chikara Murakata, Masami Kaneko, George Gessner et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 93 citations · Full text

, , +1

Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities

Hervé Schaffhauser, Joanne R. Mathiasen, Amy DiCamillo et al. · Biochemical Pharmacology · 2009 · 64 citations

, , +9

Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells

Joanne R. Mathiasen, Beth Ann McKenna, Michael S. Saporito et al. · Brain Research · 2004 · 50 citations

, , +10

Synthesis and Biological Activity of a Series of Potent Fluoromethyl Ketone Inhibitors of Recombinant Human Calpain I

Sankar Chatterjee, Mark A. Ator, Donna Bozyczko‐Coyne et al. · Journal of Medicinal Chemistry · 1997 · 45 citations

Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice

Karla Kopec, Dorothy G. Flood, Maciej Gąsior et al. · Biochemical Pharmacology · 2010 · 37 citations

, , +10

Rows per page

1–5 of 7